載入...
Salmeterol/fluticasone combination in the treatment of COPD
Clinical trials of a combination therapy of an inhaled corticosteroid, fluticasone propionate (FP), with a long-acting β(2)-agonist, salmeterol (Sal), have demonstrated a greater improvement in lung function and in quality of life measures after the combination compared with either component of alon...
Na minha lista:
主要作者: | |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
Dove Medical Press
2006
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2707153/ https://ncbi.nlm.nih.gov/pubmed/18046860 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|